Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  American Journal of Cancer Research

• Publication date

  2016-01-15

• Fields of study

  Medicine

• Identifiers
  PMID 27186409PMCID PMC4859666
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Depletion of mucin in mucin-producing human gastrointestinal carcinoma: Results from in vitro and in vivo studies with bromelain and N-acetylcysteine

  2015cited by this paper
• Protective Effects of N-acetylcysteine against 5-Fluorouracil- Induced Pulmonary Toxicity in Albino Rats

  2014cited by this paper
• Cisplatin otoprotection using transtympanic L‐N‐acetylcysteine: A pilot randomized study in head and neck cancer patients

  2014cited by this paper
• Intraperitoneal antineoplastic drug delivery: experience with a cyclophosphamide, vincristine and prednisolone protocol in cats with malignant lymphoma.

  2014cited by this paper
• Bioavailability of cyclophosphamide and vincristine after intraperitoneal administration in cats

  2014cited by this paper
• Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cells

  2014cited by this paper
• Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer

  2014cited by this paper
• N-acetyl-L-cysteine sensitizes pancreatic cancers to gemcitabine by targeting the NFκB pathway.

  2014cited by this paper
• Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy

  2014cited by this paper
• Mucins and tumor resistance to chemotherapeutic drugs.

  2014cited by this paper
• N-acetylcysteine rescue protocol for nephrotoxicity in children caused by ifosfamide.

  2013cited by this paper
• An Undesired Effect of Chemotherapy

  2013cited by this paper
• Ultrastructural evaluation of the effect of N-acetylcysteine on methotrexate nephrotoxicity in rats.

  2013cited by this paper
• Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis

  2012cited by this paper
• Peritoneal surface malignancies and regional treatment: a review of the literature.

  2012influential reference
• N-acetylcysteine potentiates doxorubicin-induced ATM and p53 activation in ovarian cancer cells

  2012cited by this paper
• Cytoreductive Surgery Plus Hyperthermic Perioperative Chemotherapy for Selected Patients with Peritoneal Metastases from Colorectal Cancer: A New Standard of Care or an Experimental Approach?

  2012cited by this paper
• Adjuvant Bidirectional Chemotherapy Using an Intraperitoneal Port

  2012influential reference
• Primary colonic lymphoma: an analysis of 74 cases with localized large‐cell lymphoma

  2011cited by this paper
• Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis.

  2011cited by this paper
• A new standard of care for the management of peritoneal surface malignancy.

  2011influential reference
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial.

  2011cited by this paper
• Possible involvement of oxidative stress in 5-fluorouracil-mediated myelosuppression in mice.

  2011cited by this paper
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

  2011cited by this paper
• Pharmacology of perioperative 5‐Fluorouracil

  2010influential reference
• N‐acetylcysteine modulates doxorubicin‐induced oxidative stress and antioxidant vitamin concentrations in liver of rats

  2010cited by this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

  2009cited by this paper
• Different tissue distribution of paclitaxel with intravenous and intraperitoneal administration.

  2009cited by this paper
• Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric Cancer

  2009cited by this paper
• Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery

  2009cited by this paper
• Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites

  2007cited by this paper
• The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.

  2007cited by this paper
• N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data

  2006cited by this paper
• New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?

  2006cited by this paper
• Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A New Standard of Care for Appendiceal Mucinous Tumors with Peritoneal Dissemination

  2005cited by this paper
• Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy.

  2005cited by this paper
• Protection against Cisplatin-Induced Toxicities by N-Acetylcysteine and Sodium Thiosulfate as Assessed at the Molecular, Cellular, and in Vivo Levels

  2005cited by this paper
• Bone Marrow Chemoprotection without Compromise of Chemotherapy Efficacy in a Rat Brain Tumor Model

  2004cited by this paper
• Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy

  2004cited by this paper
• Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics

  2003cited by this paper
• Evaluation of intraperitoneal vincristine in malignant peritoneal effusion.

  2003cited by this paper
• The antioxidant n-acetylcysteine increases 5-fluorouracil activity against colorectal cancer xenografts in nude mice

  2001cited by this paper
• Antioxidants enhance the susceptibility of colon carcinoma cells to 5-fluorouracil by augmenting the induction of the bax protein.

  2001cited by this paper
• For the clinical application of thermochemotherapy given at mild temperatures.

  1999cited by this paper
• Pharmacokinetics of Cisplatin Administered by Continuous Hyperthermic Peritoneal Perfusion (CHPP) to Patients with Peritoneal Carcinomatosis

  1999cited by this paper
• Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice.

  1998cited by this paper
• Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model

  1997cited by this paper
• Peritoneal-plasma barrier.

  1996cited by this paper
• Synergism between N‐acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models

  1996cited by this paper
• Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy.

  1989cited by this paper
• Modulation of pulmonary metastasis (Lewis lung carcinoma) by bromelain, an extract of the pineapple stem (Ananas comosus)

  1988cited by this paper
• Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update.

  1988cited by this paper
• N-acetylcysteine in the prevention of cyclophosphamide induced haemorrhagic cystitis.

  1986cited by this paper
• N-acetylcysteine in the prevention of cyclophosphamide induced haemorrhagic cystitis.

  1986cited by this paper
• [Treatment of advanced cancer of the colon and rectum with the combination of 5-fluorouracil, imidazolecarboxamide and vincristine].

  1983cited by this paper
• Protection by N-acetylcysteine of cyclophosphamide metabolism - related in vivo depression of mixed function oxygenase activity and in vitro denaturation of cytochrome P-450.

  1980cited by this paper
• In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C.

  1980cited by this paper
• Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.

  1973cited by this paper
• [Anticancer treatment and bromelains].

  1972cited by this paper

• Intra-Tumoral Mucolytic Therapy for Unresectable Pseudomyxoma Peritonei: Results of a Single-Center Expanded Access Program.

  2026cites this paper
• Niosomal Hydrogel Loaded With Bromelain: A Promising Solution for Reducing Skin Collagen in Scleroderma Patients

  2025cites this paper
• Safety of BromAc® with Mitomycin C during hyperthermic intraperitoneal chemotherapy (HIPEC): a preclinical study.

  2025cites this paper
• Effect of N-Acetylcysteine on Cisplatin Toxicity: A Review of the Literature

  2024cites this paper
• Exploring the Therapeutic Potential of Bromelain: Applications, Benefits, and Mechanisms

  2024cites this paper
• Enhancement of treatment efficacy of hepatic tumours using Trans-arterial-chemoembolization.

  2023cites this paper
• Combination chemotherapy in rodents: a model for chemotherapy-induced neuropathic pain and pharmacological screening

  2023cites this paper
• Intraperitoneal BromAc® Does Not Interfere with the Healing of Colon Anastomosis

  2023cites this paper
• Bromelain and acetylcysteine (BromAc®): a novel approach to the treatment of mucinous tumours.

  2023cites this paper
• A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAc.

  2022cites this paper
• Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities.

  2022cites this paper
• Encapsulation of Bromelain in Combined Sodium Alginate and Amino Acid Carriers: Experimental Design of Simplex-Centroid Mixtures for Digestibility Evaluation

  2022cites this paper
• Bromelain: A Potent Phytomedicine

  2022cites this paper
• Blockade of ALDH in Cisplatin-Resistant Ovarian Cancer Stem Cells In Vitro Synergistically Enhances Chemotherapy-Induced Cell Death

  2022cites this paper
• Comparison Of Efficacy Of Oral Bromelain and Serratiopeptidase For The Control Of Postoperative Sequelae Following Third Molar Surgery - A Comparative Study

  2021cites this paper
• Arginine Deiminase Induces Immunogenic Cell Death and Is Enhanced by N-acetylcysteine in Murine MC38 Colorectal Cancer Cells and MDA-MB-231 Human Breast Cancer Cells In Vitro

  2021cites this paper
• The effect of N‐acetyl cysteine on the volume of uterine leiomyoma: A randomized clinical trial

  2021cites this paper
• Addition of bromelain and acetylcysteine to gemcitabine potentiates tumor inhibition in vivo in human colon cancer cell line LS174T.

  2021cites this paper
• Bromelain, a Group of Pineapple Proteolytic Complex Enzymes (Ananas comosus) and Their Possible Therapeutic and Clinical Effects. A Summary

  2021cites this paper
• The Biological Synthesis and the Function of Mucin 2 in Pseudomyxoma Peritonei

  2021cites this paper
• Role of human nucleoside transporters in pancreatic cancer and chemoresistance

  2021cites this paper
• CMAR_A_324982 7909..7917

  2021cites this paper
• Bromelain

  2020cites this paper
• Does Bromelain-Cisplatin Combination Afford In-Vitro Synergistic Anticancer Effects on Human Prostatic Carcinoma Cell Line, PC3?

  2020cites this paper
• Novel use of Bromelain in Management of Chronic Rectus Sheath Hematoma: A Case Report

  2020cites this paper
• pH-sensitive bromelain nanoparticles by ortho ester crosslinkage for enhanced doxorubicin penetration in solid tumor.

  2020cites this paper
• Novel use of bromelain in the management of infected prosthetic surgical mesh after ventral hernia repair

  2020cites this paper
• Bromelain-based chemo-herbal combination effect on human cancer cells: in-vitro study on AGS and MCF7 proliferation and apoptosis

  2020cites this paper
• Enhancing the potency of chemotherapeutic agents by combination with bromelain and N-acetylcysteine - an in vitro study with pancreatic and hepatic cancer cells.

  2020cites this paper
• Mucins in pancreatic cancer: A well‐established but promising family for diagnosis, prognosis and therapy

  2020cites this paper
• Bromelain and N-acetylcysteine as therapeutic agents for soft tissue sarcoma

  2019cites this paper
• A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study.

  2019cites this paper
• Interaction between phytotherapy and oral anticancer agents: prospective study and literature review

  2019cites this paper
• New Treatment Modalities for the Management of Peritoneal Metastases

  2018cites this paper
• The effect of hyperthermia (42°C) on the anti-tumoral effect of bromelain, N-acetyl cysteine, chemotherapeutic agents and their combinations - an in vitro evaluation

  2018cites this paper
• Bromelain-immobilized and lactobionic acid-modified chitosan nanoparticles for enhanced drug penetration in tumor tissues.

  2018cites this paper
• Enzyme decorated drug carriers: Targeted swords to cleave and overcome the mucus barrier☆

  2017cites this paper
• Mucins in pancreatic cancer: biological role, implications in carcinogenesis and applications in diagnosis and therapy.

  2017cites this paper
• A Novel Approach to Peritoneal Dissemination of Mucin-Expressing Malignancies of Gastrointestinal Origin

  2016cites this paper
• Depletion of mucin in mucin-producing human gastrointestinal carcinoma: Results from in vitro and in vivo studies with bromelain and N-acetylcysteine

  2015cites this paper